10 hours Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last? Zacks

Verve Therapeutics (VERV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn’t suggest further strength down the road.